Abstract:Cancer immune responses are complex cellular processes in which cytokine-receptor interactions play central roles in cancer development and response to therapy; dysregulated cytokine-receptor communication may lead to pathological processes, including cancer, autoimmune diseases, and cytokine storm; however, our knowledge regarding cytokine-mediated cell-cell communication (CCI) in different cancers remains limited. The present study presents a single-cell and pan-cancer-level transcriptomics integration of 41,900 cells across 25 cancer types. We developed a single-cell method to actively express 62 cytokine-receptor pairs to reveal stable cytokine-mediated cell communications involving 84 cytokines and receptors. The correlation between the sample-based CCI profile and the interactome analysis indicates multiple cytokine- receptor modules including TGFB1, IL16ST, IL15, and the PDGF family. Some isolated cytokine interactions, such as FN1-IL17RC, displayed diverse functions within over ten single-cell transcriptomics datasets. Further functional enrichment analysis revealed that the constructed cytokine-receptor interaction map is associated with the positive regulation of multiple immune response pathways. Using public TCGA pan-cancer mutational data, co-mutational analysis of the cytokines and receptors provided significant co-occurrence features, implying the existence of cooperative mechanisms. Analysis of 10,967 samples from 32 TCGA cancer types revealed that the 84 cytokine and receptor genes are significantly associated with clinical survival time. Interestingly, the tumor samples with mutations in any of the 84 cytokines and receptors have a substantially higher mutational burden, offering insights into antitumor immune regulation and response. Clinical cancer stage information revealed that tumor samples with mutations in any of the 84 cytokines and receptors stratify into earlier tumor stages, with unique cellular compositions and clinical outcomes. This study provides a comprehensive cytokine-receptor atlas of the cellular architecture in multiple cancers at the single-cell level.

An atlas of cell-type-specific interactome networks across 44 human tumor types

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

An Atlas of Tumor Metabolism Uncovers Gene-Metabolite Interactions

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network

A pathology atlas of the human cancer transcriptome

An atlas of protein-protein associations of human tissues prioritizes candidate disease genes

A human functional protein interaction network and its application to cancer data analysis

An atlas of genetic effects on cellular composition of the tumor microenvironment

Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types

Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes

A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Pan-cancer single-cell landscape of tumor-infiltrating T cells

State of the Interactomes: an evaluation of molecular networks for generating biological insights

HCNetlas: Human cell network atlas enabling cell type-resolved disease genetics

Comprehensive Characterization of the Integrin Family Across 32 Cancer Types

Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers

Identification of Cytokine-Induced Cell Communications by Pan-Cancer Meta-Analysis.

Genomic and immune landscape in hepatocellular carcinoma: Implications for personalized therapeutics

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.